FABP5

FABP5 Informations sur la molécule

Nom anglais	Fatty acid binding protein 5	Nombre de médicaments commercialisés	0
Nombre de médicaments cliniques	1	Alias de la cible	Fatty Acid Binding Protein 5，PA-FABP，E-FABP，Psoriasis-Associated Fatty Acid-Binding Protein Homolog，Fatty Acid Binding Protein 5 (Psoriasis-Associated)，Epidermal-Type Fatty Acid-Binding Protein，Fatty Acid-Binding Protein 5，KFABP，Fatty Acid-Binding Protein， Epidermal，PAFABP，EFABP，FABP5
Phase de R&D la plus avancée	Phase 1 Clinical

Nom anglais	Fatty acid binding protein 5
Alias de la cible	Fatty Acid Binding Protein 5，PA-FABP，E-FABP，Psoriasis-Associated Fatty Acid-Binding Protein Homolog，Fatty Acid Binding Protein 5 (Psoriasis-Associated)，Epidermal-Type Fatty Acid-Binding Protein，Fatty Acid-Binding Protein 5，KFABP，Fatty Acid-Binding Protein， Epidermal，PAFABP，EFABP，FABP5
Nombre de médicaments commercialisés	0
Nombre de médicaments cliniques	1
Phase de R&D la plus avancée	Phase 1 Clinical

FABP5 Liste de produits

Attribut
Protein (1)
Bibliothèque de produits
En ligne (1)
Espèces
Human (1)
Étiquette
His Tag (1)
Marqueur
Unconjugated (1)

Numéro de produit	Espèces	Système d'expression	Description du produit	Structure protéique	Pureté	Caractéristiques	Pré-commande/Commande
FA5-H5140	Human	E. coli	Human FABP5 / E-FABP Protein, His Tag				Ajouter au panier

Quantité totale1

FABP5Contexte de la molécule

Fatty acid-binding protein 5 (FABP5), is also known as Fatty acid-binding protein, epidermal (E-FABP), Psoriasis-associated fatty acid-binding protein homolog (PA-FABP). FABP5 / E-FABP belongs to the calycin superfamily and fatty-acid binding protein (FABP) family. FABP5 / E-FABP is highly expressed in psoriatic skin. FABP5 / E-FABP has high specificity for fatty acids and has highest affinity for C18 chain length. FABP5 may be involved in keratinocyte differentiation.

FABP5Alias de la molécule

FABP5,E-FABP,PA-FABP

Informations sur les médicaments cliniques

Nom anglais	Code de recherche	Phase de R&D	Entreprise	Indication	Essai clinique
ART-2612	ART-2612; ART 26.12; ART26.12	Phase 1 Clinical	Stony Brook University, The Research Foundation of the State University of New York	Anxiety; Breast Neoplasms; Neoplasms; Pain; Peripheral Nervous System Diseases; Prostatic Neoplasms	Details